Schroder Investment Management Group Terns Pharmaceuticals, Inc. Transaction History
Schroder Investment Management Group
- $122 Billion
- Q3 2025
A detailed history of Schroder Investment Management Group transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 217,931 shares of TERN stock, worth $4.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
217,931
Previous 376,204
42.07%
Holding current value
$4.9 Million
Previous $1.4 Million
18.03%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TERN
# of Institutions
146Shares Held
87.1MCall Options Held
518KPut Options Held
117K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$184 Million2.36% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$170 Million1.96% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$168 Million0.99% of portfolio
-
Morgan Stanley New York, NY7.25MShares$163 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$155 Million5.45% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $846M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...